Postdoctoral position (M/F) in medicinal chemistry: understanding the role of ML-IAP TAMs in Glioblastomas

Glioblastomas (GBM) are the most common and aggressive primary brain tumors in humans. Immunotherapies, which revolutionized the treatment of systemic tumors, remain inefficient for GBM, most likely due to a high immunosuppressive environment.